MANUFACTURING
JSE-listed pharmaceutical group Adcock Ingram Holdings expects to report a 24% to 25% year-on-year increase in earnings per share (EPS) to between 492c and 495c for the financial year ended June 30.
This compares with EPS of 396c posted in the prior financial year.
Please enter the email address that you used to subscribe to Research Channel. Your password will be sent to this address.
Don't have any login details?
Free Trial Access